Earnings Releases

Camp4 Therapeutics Corp reported the first quarter ended March 31, 2026 results: net income Net loss for the quarter ended March 31, 2026 was $18.3 million, compared to $12.4 million for the quarter ended March 3.

“CAMP4 Therapeutics Corporation ("CAMP4") (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced financial results for the first quarter ended March 31, 2026, and provided recent corporate highlights.”

Arlo Technologies, Inc. reported first quarter ended March 29, 2026 results: revenue $150,382, net income $15 million, EPS $0.14.

“$6.4 million resulting in a 51% return. Page 1 Three Months Ended March 29, 2026 December 31, 2025 March 30, 2025 (In thousands, except percentage and per share data) Revenue $ 150,382 $ 141,297 $ 119,066 GAAP gross margin 48.3 % 46.4 % 44.3 % Non-GAAP gross margin (2) 50.1 % 47.8 % 45.5 % GAAP earnings (loss) per share - basic $ 0.14 $ 0.05 $ (0.01) Non-GAAP”

Nuveen Churchill Direct Lending Corp. reported financial results for first quarter ended March 31, 2026.

“NEW YORK, May 7, 2026 - Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) (“NCDL” or the “Company”), a business development company externally managed by its investment adviser, Churchill DLC Advisor LLC (the “Adviser”), and by its sub-adviser, Churchill Asset Management LLC (“Churchill”), today reported financial results for the first quarter ended March 31, 2026.”

IN8BIO, INC. reported the first quarter ended March 31, 2026 results: net income a net loss of $5.1 million, or $0.26 per basic and diluted common share, EPS $0.26 per basic and diluted common share.

“The Company reported a net loss of $5.1 million, or $0.26 per basic and diluted common share, for the three months ended March 31, 2026, compared with a net loss of $5.6 million, or $2.16 per basic and diluted common share, for the comparable prior year period.”

Corsair Gaming, Inc. reported first quarter 2026 results: revenue $354.5 million, net income increased $23.4 million YoY, EPS $0.11 / $0.27 GAAP / Non-GAAP EPS.

“adjusted EBITDA margin. • GAAP diluted earnings per share increased 210% YoY to $0.11, while non-GAAP diluted earnings per share increased 145% YoY to $0.27. • Revenue of $354.5 million, above the midpoint of our guided range, reflecting strong growth in Gamer and Creator Peripherals, partially offset by softer demand in Gaming Components and Systems driven by”

BridgeBio Pharma, Inc. reported the first quarter ended March 31, 2026 results: revenue $194.5 million.

“except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates - $194.5 million in total first quarter revenues, comprised of $180.6 million of U.S. Attruby® net product revenue, with strong prescribing growth and patient persistence driving continued”

Beam Therapeutics Inc. reported financial results for quarter ended March 31, 2026.

“On May 7, 2026, the Company issued a press release announcing its financial results for the quarter ended March 31, 2026.”

BlackSky Technology Inc. reported the first quarter ended March 31, 2026 results: revenue $20.8 million, net income Net loss for the first quarter of 2026 was $29.7 million. Guidance raised.

“rapidly entered commercial operations in less than one week • Next Gen-3 satellite ready to be shipped Financial Results Revenues Total revenue for the first quarter of 2026 was $20.8 million, compared to $29.5 million in the first quarter of 2025. The difference reflects the benefit in the first quarter of 2025 of $9.0 million related to a program milestone of a new”

AerSale Corp reported the fiscal quarter ended March 31, 2026 results: revenue $70.6 million, net income $3.5 million, EPS $(0.07) per diluted share.

“by specific reference in such a filing. ​ --- EX-99.1 (EX-99.1) --- ​ Exhibit 99.1 ​ AerSale Reports First Quarter 2026 Results ​ First Quarter 2026 Highlights ● Revenue of $70.6 million versus $65.8 million in the prior year period ● Net loss of $3.5 million versus net loss of $5.3 million in the prior year period ● Adjusted net income 1 of $0.1 million versus”

Trulieve Cannabis Corp. reported first quarter ended March 31, 2026 results: revenue $287 million, net income $2 million.

“as Exhibit 99.1. --- EX-99.1 (EX-99.1) --- Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation • First quarter revenue of $287 million, with 59% gross margin • Positive net income of $2 million and Adjusted EBITDA of $100 million* • Rescheduling of medical marijuana to Schedule III enabled applications for DEA”

Karat Packaging Inc. updated its the 2026 second quarter and full-year 2026 guidance (initiated).

“Guidance • Net sales for the 2026 second quarter expected to increase by 8 to 10 percent from the prior-year quarter. • Gross margin for the 2026 second quarter expected to be within 35 to 37 percent, excluding potential tariff refund impact under the current trade policy. • Adjusted EBITDA margin for the 2026 second quarter expected to be within 11 to 13 percent, excluding potential tariff refund impact under the current trade policy. • N et sales for full-year 2026 expected to increase by low double-digits from the prior year. • Gross margin for full-year 2026 expected to be within 34 to 36%, excluding potential tariff refund impact under the current trade policy. • Adjusted EBITDA margin for full-year 2026 expected to be within 11 to 13 percent, excluding potential tariff refund impact under the current trade policy.”

Karat Packaging Inc. reported the quarter ended March 31, 2026 results: revenue $116.9 million, net income $7.1 million, EPS $0.34 per diluted share.

“First Quarter 2026 Highlights • Net sales of $116.9 million , up 12.9 percent , from $103.6 million in the prior-year quarter. • Gross profit of $41.5 million , up 1.9 percent , from $40.8 million in the prior-year quarter. • Gross margin of 35.5 percent , reflecting an expected decrease from 39.3 percent in the prior-year quarter due to elevated tariffs. • Net income of $7.1 million , up 4.8 percent , from $6.8 million in the prior-year quarter. • Net income margin of 6.1 percent versus 6.6 percent in the prior-year quarter. • Adjusted EBITDA of $12.5 million versus $11.9 million in the prior-year quarter. • Adjusted EBITDA margin of 10.7 percent versus 11.5 percent i n the prior-year quarter. Guidance • Net sales for the 2026 second quarter expected to increase by 8 to 10 percent from the prior-year quarter. • Gross margin for the 2026 second quarter expected to be within 35 to 37 percent, excluding potential tariff refund impact under the current trade policy. • Adjusted EBITDA marg”

Lyft, Inc. reported the first quarter ended March 31, 2026 results: revenue $1.7 billion, net income $14.2 million.

“and drives confidence in our growth to accelerate in Q2.” First Quarter 2026 Financial Highlights • Gross Bookings of $4.9 billion, up 19% year over year. • Revenue of $1.7 billion, up 14% year over year. • Net income of $14.2 million compared to $2.6 million in Q1'25. ◦ Net income as a percentage of Gross Bookings of 0.3% compared to 0.1% in Q1'25. •”

Privia Health Group, Inc. reported first quarter ended March 31, 2026 results: revenue $ 603.8, net income $ 3.1, EPS $ 0.02. Guidance reaffirmed.

“results for the first quarter ended March 31, 2026. Three Months Ended March 31, (unaudited; $ in millions, except per share amounts) 2026 2025 Change (%) * Total revenue $ 603.8 $ 480.1 25.8 % Gross profit $ 125.6 $ 103.6 21.2 % Operating income $ 7.4 $ 5.2 42.2 % Net income a $ 3.1 $ 4.2 (27.4) % Non-GAAP adjusted net income b $ 24.3 $ 19.9 22.3 % Net”

ALTA EQUIPMENT GROUP INC. updated its 2026 fiscal year guidance (lowered).

“The Company updates our guidance range and now expects to report Adjusted EBITDA* between $167.5 million and $182.5 million for the 2026 fiscal year, primarily attributable to first quarter performance.”

ALTA EQUIPMENT GROUP INC. reported first quarter ended March 31, 2026 results: revenue $410.5 million, net income Net loss available to common stockholders of $(20.3) million, EPS $(0.62). Guidance reaffirmed.

“Exhibit 99.1 Alta Equipment Group Announces First Quarter 2026 Financial Results First Quarter Financial Highlights: • Total revenues decreased $12.5 million year over year to $410.5 million. On an organic basis*, revenues decreased $8.6 million year over year, or 2.1% • Material Handling revenues decreased $7.4 million year over year to $150.5 million, while”

Arcturus Therapeutics Holdings Inc. reported financial results for the quarter ended March 31, 2026.

“today announced its financial results for the quarter ended March 31, 2026, and provided corporate updates.”

Cerence Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $64.2 million, net income $1.7 million, EPS $0.04. Guidance raised.

“Cerence AI Delivers Strong Q2 FY26 Results with Revenue Above Guidance; Raises and Refines Full-Year Outlook Headlines • Exceeded Q2 expectations with $64.2 million in revenue and $7.2 million in Adjusted EBITDA, both above the high end of guidance; net income within range at $1.7 million; $14.1 million in operating cash flow; and $13.6”

Climb Bio, Inc. reported financial results for first quarter ended March 31, 2026.

“On May 7, 2026, Climb Bio, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026.”

CoreWeave, Inc. reported Three Months Ended March 31, 2026 results: revenue $2,078, net income $(740), EPS $(1.40).

“First Quarter 2026 Financial Highlights (In millions, except percentages and per share amounts) Three Months Ended March 31, 2026 2025 Revenue $ 2,078 $ 982 Operating expenses 2,222 1,009 Operating loss $ (144) $ (27) Operating loss margin (7) % (3) % Interest expense, net $ (536) $ (264) Net loss $ (740) $ (315) Net loss margin (36) % (32) % Basic net loss per share $ (1.40) $ (1.40) Diluted net loss per share $ (1.40) $ (1.49)”

10x Genomics, Inc. reported the first quarter ended March 31, 2026 results: revenue $150.8 million, net income Net loss was $13.5 million. Guidance reaffirmed.

“Revenue was $150.8 million for the first quarter of 2026, a 3% decrease from the corresponding period of 2025.”

Aardvark Therapeutics, Inc. reported first quarter ended March 31, 2026 results: revenue $91.2 million, net income net loss of $21.6 million.

“Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates ARD-101 and ARD-201 programs on voluntary pause; further guidance expected in Q2 2026 $91.2 million in cash, cash equivalents and short-term investments as of March 31, 2026, supports projected operations into mid-2027 SAN DIEGO, May 7, 2026 (GLOBE NEWSWIRE) -- Aardvark”

MBX Biosciences, Inc. reported first quarter ended March 31, 2026 results: net income Net loss for the three months ended March 31, 2026, was $23.5 million.

“Net loss for the three months ended March 31, 2026, was $23.5 million compared to a net loss of $23.9 million for the same period in 2025.”

AvePoint, Inc. reported the first quarter ended March 31, 2026 results: revenue Total revenue was $117.2 million. Guidance raised.

“2026 Financial Results First quarter SaaS revenue of $93.4 million, representing 35% year-over-year growth, 29% on a constant currency basis First quarter Total revenue of $117.2 million, representing 26% year-over-year growth, 20% on a constant currency basis Total ARR of $435.2 million, representing 26% year-over-year growth, 23% adjusted for FX JERSEY CITY,”

TerrAscend Corp. reported first quarter ended March 31, 2026 results: revenue $65.5 million, net income ($6.8 million).

“Net Revenue of $65.5 million, compared to $64.3 million in the first quarter of 2025 • Gross Profit Margin of 52.8% • GAAP Net Loss from continuing operations was $6.8 million • EBITDA from continuing operations1 was $17.3 million • Adjusted EBITDA from continuing operations1 was $17.4 million or 26.5% of net revenue • Net Cash provided from continuing operations was $8.7 million • Free Cash Flow1 was $7.8 million”

Morgan Stanley Direct Lending Fund reported the first quarter ended March 31, 2026 results: net income $40.5 million, or $0.47 per share, EPS $(0.05) per share.

“Capital Partners Adviser Inc. (the “Adviser”), today announced its financial results for the first quarter ended March 31, 2026. QUARTERLY HIGHLIGHTS • Net investment income of $40.5 million, or $0.47 per share, as compared to $42.4 million, or $0.49 per share, for the quarter ended December 31, 2025; • Net asset value of $19.81 per share, as compared to $20.26 as of”

Katapult Holdings, Inc. reported first quarter ended March 31, 2026 results: revenue $79.0 million, net income $5.7 million.

“First Quarter 2026 Financial Highlights (All comparisons are year-over-year unless stated otherwise.) • Gross originations were $64.2 million, an increase of 0.1%. Excluding the home furnishings and mattress category, gross originations grew 17.5% year-over-year. • Total revenue was $79.0 million, an increase of 9.8%. • Total operating expenses in the first quarter decreased by $1.0 million. Our fixed cash operating expenses 2 , which exclude transaction related costs and other non-cash and variable expenses, decreased by 10.8% year-over-year. • Income from operations was $4.3 million, an improvement compared with a loss of $(0.5) million in the first quarter of 2025. • Net income was $5.7 million for the first quarter of 2026, a 200% improvement compared with net loss of $(5.7) million reported for the first quarter of 2025.”

Werewolf Therapeutics, Inc. reported first quarter ended March 31, 2026 results: net income Net loss was $13.5 million for the first quarter of 2026.

“Net loss was $13.5 million for the first quarter of 2026, compared to $18.1 million for the same period in 2025.”

BILL Holdings, Inc. reported the fiscal fourth quarter ending June 30, 2026 and the full fiscal year ending June 30, 2026 results: EPS $0.69 - $0.72. Guidance initiated.

“We are providing the following guidance for the fiscal fourth quarter ending June 30, 2026 and the full fiscal year ending June 30, 2026. Q4 FY26 Guidance FY26 Guidance Total revenue (millions) $425.0 - $435.0 $1,642.0 - $1,652.0 Year-over-year total revenue growth 11% - 13% 12% - 13% Core revenue (millions) $392.0 - $402.0 $1,496.3 - $1,506.3 Year-over-year core revenue growth 13% - 16% 15% - 16% Non-GAAP operating income (millions) $81.5 - $86.5 $303.6 - $308.6 Non-GAAP net income (millions) $78.0 - $82.0 $298.7 - $302.7 Non-GAAP net income per diluted share $0.69 - $0.72 $2.61 - $2.64”

BILL Holdings, Inc. reported the third fiscal quarter ended March 31, 2026 results: revenue $406.6 million, net income $12.8 million, EPS $0.12 per diluted share.

“Total revenue was $406.6 million, an increase of 13% year-over-year. • Core revenue, which consists of subscription and transaction fees, was $371.1 million, an increase of 16% year-over-year. Subscription fees were $74.5 million, up 9% year-over-year. Transaction fees were $296.6 million, up 18% year-over-year. • Float revenue, which consists of interest on funds held for customers, was $35.4 million. • Gross profit was $331.9 million, representing an 81.6% gross margin, compared to $291.0 million, or an 81.2% gross margin, in the third quarter of fiscal 2025. Non-GAAP gross profit was $346.0 million, representing an 85.1% non-GAAP gross margin, compared to $304.0 million, or an 84.9% non-GAAP gross margin, in the third quarter of fiscal 2025. • Operating loss was $0.4 million, compared to $28.9 million in the third quarter of fiscal 2025. Non-GAAP operating income was $79.8 million, compared to $53.3 million in the third quarter of fiscal 2025, an increase of 50% year-over-year. • Ne”

Vontier Corp reported Q2 2026 results: revenue $730 to $740 million, EPS $0.78 to $0.81. Guidance initiated.

“tailwind from divestiture) • Adjusted diluted net EPS in the range of $3.35 to $3.50 • Adjusted free cash flow conversion of approximately 95% Q2 2026 Outlook • Total sales of $730 to $740 million (including $15 million headwind from divestiture); Core sales growth down approximately 1% • Adjusted operating profit margin expansion of approximately 80 basis”

Vontier Corp reported full year 2026 results: revenue $2,990 to $3,040 million, EPS $3.35 to $3.50. Guidance reaffirmed.

“guidance unchanged; Total Sales and Adjusted Operating Margin revised to reflect the impact of the Teletrac divestiture (expected to close in early June) • Total sales of $2,990 to $3,040 million (including $110 million headwind from divestiture); Core sales growth midpoint of approximately 3% • Adjusted operating profit margin expansion midpoint of”

Vontier Corp reported first quarter ended April 3, 2026 results: revenue $750.6 million, net income $94.3 million, EPS $0.66.

“First Quarter 2026 Results • Sales of $750.6 million, up 1.3% vs. prior year; Core sales up 1.7% year-over-year • GAAP diluted net EPS of $0.66; Adjusted diluted net EPS of $0.80 • Operating cash flow was $46.5 million; Adjusted free cash flow was $28.0 million, representing 25% adjusted free cash flow conversion”

Cullinan Therapeutics, Inc. reported first quarter ended March 31, 2026 results: net income Net loss was $49.7 million for the first quarter of 2026.

“On May 7, 2026, Cullinan Therapeutics, Inc. (the "Company") announced its financial results for the three months ended March 31, 2026.”

Viatris Inc updated its first-quarter 2026 guidance (reaffirmed).

“On May 7, 2026 , Viatris Inc. (“Viatris” or the “Company”) issued a press release reporting the Company's financial results for the period ended March 31, 2026.”

Claritev Corp reported the first quarter ended March 31, 2026 results: revenue $244.7 million, net income $73.6 million. Guidance reaffirmed.

“Claritev Corporation Reports First Quarter 2026 Results – Q1 2026 Revenues of $244.7 million grew 5.8% compared to Q1 2025 – Net Loss of $73.6 million”

Shift4 Payments, Inc. reported financial results for the quarter ended March 31, 2026.

“Shift4 Payments, Inc. (the " Company ") announced its financial results for the quarter ended March 31, 2026.”

Palmer Square Capital BDC Inc. reported the first quarter ended March 31, 2026 results: revenue Total investment income of $26.2 million, net income Net investment income of $11.0 million or $0.35 per share, EPS $0.35 per share.

“business development company, today announced its financial results for the first quarter ended March 31, 2026. Financial and Operating Highlights • Total investment income of $26.2 million for the first quarter of 2026, compared to $31.2 million for the prior year period • Net investment income of $11.0 million or $0.35 per share for the first quarter of 2026,”

Jade Biosciences, Inc. reported the quarter ended March 31, 2026 results: net income Net loss totaled $40.4 million for the first quarter ended March 31, 2026.

“On May 7, 2026, Jade Biosciences, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended March 31, 2026.”

Oncology Institute, Inc. reported three months ended March 31, 2026 results: revenue $147.4 million, net income $2.5 million, EPS $(0.02). Guidance reaffirmed.

“maintaining high-quality care. First Quarter 2026 Financial Highlights All comparisons are to the quarter ended March 31, 2025 unless otherwise noted • Consolidated revenue of $147.4 million increased 41.2% from $104.4 million • Gross profit of $23.3 million, increased 35.2% • Net loss of $2.5 million compared to net loss of $19.6 million • Basic and diluted (loss)”

Aligos Therapeutics, Inc. reported first quarter 2026 results: net income Net loss for the three months ended March 31, 2026 was $23.0 million or basic and diluted net loss per common share of $, EPS $(2.21).

“Net loss for the three months ended March 31, 2026 was $23.0 million or basic and diluted net loss per common share of $(2.21)”

JFrog Ltd reported first quarter 2026 ended March 31, 2026 results: revenue $154.0 million, EPS $0.27.

“incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 JFrog Announces First Quarter 2026 Results • Total First Quarter Revenues of $154.0 million; up 26% Year-over-Year • First Quarter Cloud Revenues of $78.9 million; up 50% Year-over-Year • Customers with ARR greater than $1 million equaled 80, up 48% Year-over-Year •”

Opendoor Technologies Inc. reported first quarter ended March 31, 2026 results: revenue $ 720, net income $ (173).

“and June 30, 2025. First Quarter 2026 Key Highlights Three Months Ended (In millions, except percentages and non-dollar amounts) March 31, 2026 March 31, 2025 Change Revenue $ 720 $ 1,153 $ (433) Gross profit $ 72 $ 99 $ (27) Gross Margin 10.0 % 8.6 % Net loss $ (173) $ (85) $ (88) Homes sold 1,921 2,946 (1,025) Homes purchased 2,474 3,609 (1,135) Homes in”

MP Materials Corp. / DE reported the three months ended March 31, 2026 results: revenue $90,649, net income $(7,968), EPS $(0.04).

“Highlights For the three months ended March 31, 2026 vs. 2025 (in thousands, except per share data, unaudited) 2026 2025 Amount Change % Change Financial Measures: Revenue $ 90,649 $ 60,810 $ 29,839 49 % Price protection agreement income $ 42,273 $ — $ 42,273 N/M Net loss $ (7,968) $ (22,648) $ 14,680 65 % Adjusted EBITDA 2 $ 36,610 $ (2,696) $ 39,306 N/M”

Xponential Fitness, Inc. reported Full year 2026 results: revenue $260.0 million to $270.0 million. Guidance reaffirmed.

“The Company is reiterating full year 2026 outlook, which compares to 2025 results as follows: • Net new studio openings in the range of 150 to 170, or a decrease of 20% at the midpoint; • North America system-wide sales 1 in the range of $1.72 billion to $1.80 billion, or an increase of 1% at the midpoint; • Revenue in the range of $260.0 million to $270.0 million, representing a decrease of 16% at the midpoint; and • Adjusted EBITDA 5 in the range of $100.0 million to $110.0 million, representing a decrease of 6% at the midpoint.”

Xponential Fitness, Inc. reported First quarter ended March 31, 2026 results: revenue $60.7 million, net income Net loss of $0.8 million, EPS loss of $0.02 per basic share.

“boutique health and wellness brands, today reported financial results for the first quarter ended March 31, 2026. Financial Highlights: Q1 2026 Compared to Q1 2025 • Revenue of $60.7 million decreased 21%. • North America system-wide sales 1 increased 2% to $436.9 million. • North America same store sales 2 decreased 6%, compared to growth of 6%. • North America”

Harmony Biosciences Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue $215.4 million. Guidance reaffirmed.

“BIOSCIENCES REPORTS Q1 FINANCIAL RESULTS AND CONFIRMS 2026 NET REVENUE GUIDANCE OF OVER $1 BILLION; REINFORCES 2026 STRATEGIC PRIORITIES ​ WAKIX® Net Revenue Grew 17% to $215.4 Million for First Quarter 2026; On Track for Full Year 2026 Net Revenues over $1 Billion ​ Continue to Vigorously Protect WAKIX IP into 2030; Filed Suit Against AET Pharma/Sandoz”

Rocket Companies, Inc. reported the first quarter ended March 31, 2026 results: revenue $ 2,941, net income $ 297, EPS $ 0.10.

“Total revenue, net $ 2,941 $ 1,101 Total expenses $ 2,541 $ 1,324 GAAP net income (loss) $ 297 $ (212) Adjusted revenue $ 2,822 $ 1,360 Adjusted net income $ 422 $ 80 Adjusted EBITDA $ 738 $ 169 GAAP diluted earnings (loss) per share $ 0.10 $ (0.08) Adjusted diluted earnings per share $ 0.15 $ 0.04”

MARKETWISE, INC. updated its first quarter ended March 31, 2026 guidance (reaffirmed).

“On May 7, 2026, MarketWise, Inc. (the “Company”) issued an earnings press release announcing its financial results for the first quarter ended March 31, 2026.”

Open Lending Corp reported first quarter ended March 31, 2026 results: revenue $20.5 million, net income $0.5 million.

“• The Company facilitated 21,064 certified loans during the first quarter of 2026, compared to 27,638 certified loans in the first quarter of 2025. • Total revenue was $20.5 million during the first quarter of 2026, compared to $24.4 million in the first quarter of 2025. The first quarter of 2026 was impacted by a $0.7 million reduction in estimated profit”